The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

QY Research Reports

SynopsisIbrutinib is an orally bioavailable, small-molecule inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. Upon oral administration, ibrutinib binds to and irreversibly inhibits BTK activity, thereby preventing both B-cell activati.....

No Of Pages : 87
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisIcatibant Acetate is the acetate salt form of icatibant, an antagonist of the human bradykinin B2 receptor (B2R), that can be used for the treatment of hereditary angioedema (HAE). Upon administration, icatibant targets and binds to B2R, thereby preventing bra.....

No Of Pages : 88
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisIrbesartan is a nonpeptide angiotensin II antagonist with antihypertensive activity. Irbesartan selectively and competitively blocks the binding of angiotensin II to the angiotensin I receptor. Angiotensin II stimulates aldosterone synthesis and secretion by a.....

No Of Pages : 96
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisIron sucrose is used as a source of iron in patients with iron deficiency anemia with chronic kidney disease (CKD), including those who are undergoing dialysis (hemodialysis or peritoneal) and those who do not require dialysis. Due to less side effects than ir.....

No Of Pages : 96
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisKetorolac Tromethamine is the tromethamine salt of ketorolac, a synthetic pyrrolizine carboxylic acid derivative with anti-inflammatory, analgesic and antipyretic properties. Ketorolac tromethamine, a non-selective inhibitor of the cyclooxygenases (COX), inhib.....

No Of Pages : 96
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisThalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implica.....

No Of Pages : 85
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisLevetiracetam is a relatively unique anticonvulsant that is typically used in combination with other antiepileptic medications for partial onset seizures. Levetiracetam has been linked to rare instances of serum aminotransferase and alkaline phosphatase elevat.....

No Of Pages : 101
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisLevocetirizine Dihydrochloride is the dihydrochloride salt form of the active levorotatory enantiomer of cetirizine, levocetirizine; a third generation, non-sedating, selective histamine H1 receptor antagonist, with antihistamine, anti-inflammatory and potenti.....

No Of Pages : 101
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisLifitegrast is an N-acyl-L-alpha-amino acid obtained by formal condensation of the carboxy group of N-[2-(1-benzofuran-6-carbonyl)]-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid with the amino group of 3-(methanesulfonyl)-L-phenylalanine. Used .....

No Of Pages : 86
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisThe global Levofloxacin Hemihydrate API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Levofloxacin Hemihydrate API is estim.....

No Of Pages : 92
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00